Teleflex to Present at Morgan Stanley's Healthcare Conference
Management of Teleflex Incorporated (NYSE: TFX) is excited to announce that they will be presenting at the renowned Morgan Stanley Annual Global Healthcare Conference. The event is set to take place at the Sheraton New York Times Square, and Teleflex's presentation is scheduled for the afternoon.
Conference Details and Access
The exact time for the presentation is 3:20 p.m. (ET) on the day of the event. For those interested in viewing the presentation live, there will be an audio webcast available on the investor section of the Teleflex website. This is a perfect opportunity for investors and stakeholders to engage with the company's current initiatives and insights into the healthcare technology landscape.
About Teleflex Incorporated
Teleflex is a leading global provider of medical technologies committed to improving health and quality of life for patients around the world. The company's mission is driven by a vision to become the most trusted partner in healthcare, emphasizing innovation and quality in their product offerings.
Trusted Brands Offering Diverse Solutions
Among the extensive range of products, Teleflex offers advanced solutions in various medical fields, including anesthesia, emergency medicine, interventional cardiology, radiology, surgical, vascular access, and urology. The company proudly features well-known brands such as Arrow™, Barrigel™, Deknatel™, QuikClot™, LMA™, Pilling™, Rüsch™, UroLift™, and Weck™. Together, these products embody Teleflex’s commitment to high-quality healthcare solutions.
Teleflex's Commitment to Innovation
At Teleflex, there is a strong belief that the synergy of talented individuals driven by purpose can significantly shape the future of healthcare. Their continued focus on innovation ensures that they not only meet current healthcare needs but also anticipate future demands, paving the way for groundbreaking technologies in medical care.
Vision for the Future of Healthcare
Teleflex is dedicated to empowering the future of healthcare. With a focus on developing products that facilitate better patient outcomes, the company aims to remain at the forefront of medical technology. This commitment is reflected in the ongoing investment in research and development, critical to sustaining their leadership in the healthcare space.
Contact Information
For more detailed inquiries, stakeholders and interested parties can reach out directly to Teleflex. Lawrence Keusch serves as the Vice President of Investor Relations and Strategy Development. He can be contacted via telephone at 610-948-2836 or through their investor relations email.
Frequently Asked Questions
1. What is the date of Teleflex's presentation at the conference?
The company will present on September 9, 2025.
2. Where will the conference take place?
The conference will be held at the Sheraton New York Times Square.
3. How can investors access the presentation?
Investors can access the live audio webcast of the presentation on Teleflex's investor relations webpage.
4. What areas do Teleflex's medical solutions cover?
Teleflex offers medical technologies across various areas, including anesthesia, emergency medicine, cardiology, and urology.
5. Who can be contacted for investor inquiries?
Lawrence Keusch, Vice President of Investor Relations and Strategy Development, is the point of contact for investor-related inquiries.
